期刊文献+

胃肠道恶性肿瘤根治术后腹腔化疗的方法 被引量:5

Intraperitoneal chemotherapy for gastrointestinal cancer following radical operation
暂未订购
导出
摘要 目的 探讨胃肠道的恶性肿瘤根治术后腹腔化疗方法及其相关副作用。方法 应用直接注入法、腹腔置管法、腹腔置泵法三种手段进行腹腔化疗 ,选用的药物是 :5 Fu、CF、HCPT、PDD、VP 16等联合化疗药物组合有三种 :(1) 5 Fu、CF、HCPT ;(2 ) 5 Fu、CF、PDD ;(3) 5 Fu、CF、VP 16。化疗剂量与每一静脉化疗周期量相同 ,即 :5 +Fu 2 .5~ 3.0 g/周期 ;CF 10 0~ 15 0mg/天 (使用 5 Fu当天前 2~ 4小时应用 ) ;HCPT 40~ 5 0mg/周期 ;PDD 10 0mg/周期 ;VP 16 30 0~ 5 0 0mg/周期 ;输入腹腔的液体量在 2 5 0 0~ 30 0 0ml。结果 三种腹腔化疗方法各有优缺点 ,以腹腔置管法应用最为常用 ,腹腔化疗方法本身引起的主要副作用是腹胀 (10 0 % )、腹痛 (14.9% )、肠损伤、肠麻痹、腹膜炎偶有发生 ;腹腔化疗药物引起的反应有恶心、呕吐、白细胞下降、肝功损伤、腹泻、脱发等 ,但程度不重。结论 直接注入法、腹腔置管法、腹腔置泵法是值得推广的腹腔化疗方法。 Objective To study intraperitoneal chemotherapy methods for patients with gastrointestinal cancer following radical operation and relative side effects. Methods The chemotherapy regiments were injected into adbominal cavity with 2 000~3 000ml infection solution eachcycle through three methods named as direct injection, abdominal conduit dropping and abdominal pump dropping. The selected medicines including 5 Fu, CF, HCPT, PDD, VP 16 were combines as follows: 1) 5 Fu, CF and HCPT; 2) 5 Fu, CF and PDD; 3) 5 Fu, CF and VP 16 with the doses of 5 Fu being 2.5 to 3.0 g/cycle, CF 100 to 150mg/day, HCPT 40 to 50 mg cycle, PDD 100mg and VP 16 300 to 500mg/cycle respectively. Results The three chemotherapy methods had advantages and disadvantages respectively. Abdominal distention (100%) and abdominal pain ( 14.9% ) were the most side effects of intraperitoneal chemotherapy. The side effects of chemotherany agents included nausea, vomiting, leukopenia, liver function damage, diarrhea and alopecia. But they were slight. Conclusions The three methods were useful for intraperitoneal chemotherapy.
出处 《腹部外科》 2001年第1期22-24,共3页 Journal of Abdominal Surgery
关键词 胃肠道恶性肿瘤 腹腔化疗 根治术 Gastrointestinal cancer Intraperitoneal chemotherapy
  • 相关文献

参考文献3

二级参考文献1

  • 1S. Koga,N. Kaibara,Y. Iitsuka,H. Kudo,A. Kimura,H. Hiraoka. Prognostic significance of intraperitoneal free cancer cells in gastric cancer patients[J] 1984,Journal of Cancer Research and Clinical Oncology(2):236~238

共引文献43

同被引文献41

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部